As a manager overseeing research or testing laboratories, you will encounter various planned and unforeseen events necessitating the exploration of alternative staffing solutions. Both short-term fluctuations in testing volume, staffing shortages, skill gaps, and equipment downtime, as well as long-term considerations, can prompt the need to identify an outsourcing partner lab that aligns with your requirements and budget. Achieving a successful partnership involves refining your specific support requirements, selecting suitable providers, and effectively managing the collaboration.
Unbiosta Broker is a diagnostic solution provider company founded in 2019 by a group of highly experienced professionals with over 15 years of expertise in the diagnostics and biological testing field.
Unbiosta Broker is a provider of complete and innovative solution in terms of biological diagnostics, from clinical research to local and hyper-specialised medical biology, through his lab partners who are the European leaders in specialised medical biology.
to support all the players in the healthcare chain, including healthcare professionals, the pharmaceutical and diagnostics industries, and medical laboratories, helping to shape the medicine of tomorrow.
Day after day, Unbiosta business development team contribute to bring onboard a better prevention, ever earlier screening, finer and faster diagnosis.
The continuous development of new tests and the performance of analyses with high medical added value. As a partner of first-line medical analysis laboratories.
Supporting public and Private health care
With nearly 50,000 medical diagnostic tests performed every day at our partner labs who are committed to ensuring that every patient, wherever they are, has access to the most specialised and innovative techniques for screening, diagnosis, monitoring and adjusting therapies.
Unbiosta Broker daily collection network guarantee continuity of care throughout the country and internationally. Unbiosta Broker is committed to guaranteeing the same level of care, the same quality and the same access to innovation throughout Europe, for the greater benefit of patients and the medical profession.
Today, this test also makes it possible to screen for other rarer chromosome abnormalities : autosomal abnormalities, deletion and duplication greater than 7 megabases (karyotype-equivalent resolution)
Non-Invasive Prenatal Testing for trisomies 21, 18 and 13 (NIPT).
Non-Invasive Prenatal Testing for trisomies 21, 18 and 13 (NIPT))
+ Fetal gender determination
+ Sex chromosomes aneuploidies
All autosomes
+ chromosomal imbalance greater than 7Mb
All autosomes
+ chromosomal imbalance greater than 7Mb